https://vellito.com/rheumatology/382335/excision-of-nasal-glomangiomyoma-achieved-microscopic-clearance-and-no-recurrence-at-6-month-follow-up Vellito en 2026-10-19T22:39:09+00:00 Excision of nasal glomangiomyoma achieved microscopic clearance and no recurrence at 6-month follow-up Rheumatology https://vellito.com/infectious-disease/382540/conditional-micro-incentives-improve-early-hiv-care-linkage-for-women-in-rural-south-africa Vellito en 2026-10-19T22:36:36+00:00 Conditional micro-incentives improve early HIV care linkage for women in rural South Africa Infectious Disease https://vellito.com/hematology/382969/forty-independent-genetic-loci-associated-with-acute-chest-syndrome-occurrence-in-sickle-cell-disease-patients Vellito en 2026-10-19T22:30:18+00:00 Forty independent genetic loci associated with acute chest syndrome occurrence in sickle cell disease patients Hematology https://vellito.com/allergy-immunology/382779/h-pylori-shows-no-overall-link-to-pediatric-asthma-but-subgroup-signals-diverge Vellito en 2026-10-19T22:28:45+00:00 H. pylori shows no overall link to pediatric asthma, but subgroup signals diverge Allergy & Immunology https://vellito.com/allergy-immunology/382321/expert-consensus-identifies-60-to-90-incident-c3g-cases-annually-in-italy-with-94-agreement Vellito en 2026-10-19T06:42:24+00:00 Expert consensus identifies 60 to 90 incident C3G cases annually in Italy with 94% agreement Allergy & Immunology https://vellito.com/allergy-immunology/382322/pd-1pd-l1-inhibitors-plus-chemotherapy-improve-survival-in-recurrent-or-metastatic-cervical-cancer Vellito en 2026-10-19T06:39:53+00:00 PD-1/PD-L1 inhibitors plus chemotherapy improve survival in recurrent or metastatic cervical cancer Allergy & Immunology https://vellito.com/allergy-immunology/382318/ulcerative-colitis-trials-shift-toward-biologics-and-small-molecules-since-2019 Vellito en 2026-10-19T06:37:33+00:00 Ulcerative Colitis Trials Shift Toward Biologics and Small Molecules Since 2019 Allergy & Immunology https://vellito.com/diabetes-endo/382311/resistance-training-improves-egfr-in-non-dialysis-diabetic-kidney-disease-while-mind-body-exercise-reduces-uae Vellito en 2026-10-19T06:35:51+00:00 Resistance training improves eGFR in non-dialysis diabetic kidney disease while mind-body exercise reduces UAE Diabetes & Endocrinology https://vellito.com/neurology/382286/nibs-combined-with-bci-does-not-improve-upper-extremity-motor-recovery-compared-to-bci-alone Vellito en 2026-10-19T06:26:05+00:00 NIBS combined with BCI does not improve upper extremity motor recovery compared to BCI alone Neurology https://vellito.com/cardiology/382065/novel-embolization-techniques-show-promise-for-type-ii-endoleaks-after-evar Vellito en 2026-10-19T06:23:22+00:00 Novel embolization techniques show promise for Type II endoleaks after EVAR Cardiology https://vellito.com/oncology/380954/pd-1pd-l1-inhibitors-with-srs-or-fsrt-achieve-87-one-year-local-control-in-brain-metastases Vellito en 2026-10-18T22:28:07+00:00 PD-1/PD-L1 inhibitors with SRS or FSRT achieve 87% one-year local control in brain metastases Oncology https://vellito.com/infectious-disease/381082/evaluating-antibiotic-prophylaxis-durations-and-csf-leakage-risks-in-endonasal-skull-base-surgery Vellito en 2026-10-18T06:28:04+00:00 Evaluating Antibiotic Prophylaxis Durations and CSF Leakage Risks in Endonasal Skull Base Surgery Infectious Disease https://vellito.com/pediatrics/381062/subcutaneous-infliximab-maintains-clinical-remission-and-shows-high-tolerability-in-children-with-inflammatory-bowel-disease Vellito en 2026-10-18T06:25:19+00:00 Subcutaneous infliximab maintains clinical remission and shows high tolerability in children with inflammatory bowel disease Pediatrics https://vellito.com/neurology/332265/telitacicept-shows-satisfactory-response-in-complex-overlap-syndrome-case Vellito en 2026-10-18T02:45:01+00:00 Telitacicept Shows Satisfactory Response in Complex Overlap Syndrome Case Neurology https://vellito.com/oncology/380686/pik3ca-and-braf-mutations-are-associated-with-worse-progression-free-and-overall-survival-in-mcrc Vellito en 2026-10-18T01:25:31+00:00 PIK3CA and BRAF mutations are associated with worse progression-free and overall survival in mCRC Oncology https://vellito.com/oncology/380685/vacuum-assisted-breast-biopsy-of-b3-lesions-shows-1123-pooled-proportion-of-malignant-upgrades Vellito en 2026-10-18T01:23:23+00:00 Vacuum-assisted breast biopsy of B3 lesions shows 11.23% pooled proportion of malignant upgrades Oncology https://vellito.com/oncology/379832/bayesian-network-meta-analysis-evaluating-chinese-herbal-compounds-combined-with-tace-for-liver-cancer Vellito en 2026-10-17T23:24:00+00:00 Bayesian Network Meta-Analysis Evaluating Chinese Herbal Compounds Combined With TACE for Liver Cancer Oncology